跳至主要内容
临床试验/EUCTR2015-003208-22-AT
EUCTR2015-003208-22-AT进行中(未招募)1 期

Does a two-day pretreatment with capsaicin reduce postoperative hyperalgesia and pain in surgical patientsA prospective, randomized, double-blind, placebo-controlled, parallel group, single-center clinical trial on the effects of preoperative capsaicin-induced TRPV1-fiber desensitization on postoperative LTP-like pain plasticity in surgical patients - CaPsaPPP

Wilhelminen hospital0 个研究点开始时间: 2015年10月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • male or female, at least 18 years of age
  • planned elective surgery requiring incision of the abdominal wall
  • currently pain free or suffering from spontaneous pain in the last 24 hours of less than 4 on the numeric rating scale in the area of planned surgery
  • able to understand, read, and write German
  • willing and able to give informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 40

排除标准

  • patients undergoing scheduled surgery with less than 3 full days until surgery date
  • patients undergoing surgery with planned local anesthetic procedures (peripheral nerve block, , epidural or spinal anesthesia) or planned use of NMDA-receptor antagonists (i.e. ketamine i.v. or p.o.)
  • patients scheduled for postoperative controlled respiratory treatment at the intensive care unit (ICU)
  • patients under the age of 18
  • patients suffering from acute or chronic pain with an intensity of greater than 3 on the numeric rating scale (spontaneous within the last 24 hours)
  • patients currently on prescribed regular analgesic medication
  • patients suffering from any known psychiatric condition
  • patients suffering from unstable hypertension
  • patients with implanted cardiac converter or pacemaker
  • pregnancy or breast-feeding
  • known abuse of alcoholic beverages or any illegal drug
  • known allergy against interventional or placebo medication, patch contents or study assessment devices
  • unable or unwilling to give informed consent
  • unable or unwilling to follow investigator’s instructions
  • unable or unwilling to comply with study protocol
  • patients suffering from any known medical conditions which may interact with study medication, study objectives, or compliance of subject with study tasks

研究者

发起方
Wilhelminen hospital

相似试验

Does a two-day pretreatment with capsaicin reduce... | 临床试验